FindTrial
Sign In

Use of NLR and Pathological Factors Predict Axillary Lymph Node Metastasis in Patients with Breast Cancer

Use of NLR and Pathological Factors Predict Axillary Lymph Node Metastasis in Patients with Breast Cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024233
Enrollment
Unknown
Registered
2019-07-01
Start date
2019-07-31
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Gold Standard:Clinical outcome
Index test:preoperative&#32
neutrophil&#32
to&#32
lymphocyte&#32
ratio&#32
(NLR)

Sponsors

Zhujiang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Pathologic diagnosis of breast cancer with modified radical resection; 2. Surgical treatment in our hospital and complete medical records.

Exclusion criteria

Exclusion criteria: Each patient admitted to the hospital had neoadjuvant chemotherapy, a second tumor, confirmed distant metastasis of breast cancer, patients with active infection, active bleeding, hematological disorder, acute-chronic inflammation, post-splenectomy or hypersplenismsteroid usage.

Design outcomes

Primary

MeasureTime frame
Ratio of neutrophils to lymphocytes (NLR);—

Countries

China

Contacts

Public ContactSenming Wang

Zhujiang Hospital, Southern Medical University

senmingwang137@yeah.net+86 13902404566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026